Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole ER vs IR vs Placebo in Advanced Parkinson's Disease
NCT00466167Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Apr 2007; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00466167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466167.